Related Experiment Video
Updated: Jun 4, 2026

A Rat Model of EcoHIV Brain Infection
Published on: January 21, 2021
Current Views on the Pathophysiology of GB Virus C Coinfection with HIV-1 Infection
Esaki Muthu Shankar1, Pachamuthu Balakrishnan, Ramachandran Vignesh
1Department of Infectious Diseases, YRG Centre for AIDS Research and Education, VHS Hospital Campus, IT Corridor, Taramani, Chennai, 600 113, India, shankarem@yrgcare.org.
Insights
GB virus C (GBV-C) coinfection may slow HIV-1 progression by interfering with viral replication and enhancing T-cell survival. This review explores the mechanisms behind GBV-C
Area of Science:
- Virology and Immunology
- Infectious Diseases
Background:
- GB virus C (GBV-C), a Flaviviridae family virus, shares transmission routes with HIV-1.
- GBV-C replicates in hemopoietic cells, particularly T lymphocytes, without causing apparent pathology.
- HIV-1 infection is characterized by T-cell depletion and immune system collapse.
Purpose of the Study:
- To review recently proposed mechanisms explaining the beneficial role of GBV-C coinfection in HIV disease.
- To elucidate how GBV-C interferes with HIV-1 replication and disease progression.
Main Methods:
- Literature review of studies investigating GBV-C and HIV-1 coinfection.
- Analysis of proposed pathophysiological mechanisms.
- Synthesis of evidence on GBV-C's impact on T-cell survival and HIV replication.
Main Results:
- Accumulating evidence suggests GBV-C coinfection enhances survival rates in HIV-infected individuals.
- GBV-C appears to counteract HIV-1's exploitation of T-cell machinery.
- GBV-C coinfection may decelerate HIV-1 disease progression.
Conclusions:
- GBV-C coinfection presents a potentially beneficial interaction in the context of HIV disease.
- Understanding the mechanisms of GBV-C's protective effects is crucial for therapeutic strategies.
- Further research is warranted to fully elucidate the complex interplay between GBV-C and HIV-1.
Abstract:
GB virus C (GBV-C), a member of the Flaviviridae family of viruses, recently received considerable attention largely owing to its potential role in decelerating HIV-1 disease progression by interfering with HIV replication. With similar transmission features, GBV-C is parenterally transmitted, similar to the serum hepatitis viruses and HIV-1, and replicates in hemopoietic cells and T lymphocytes in particular, with no observable disease pathology. Progressive T-cell depletion and subsequent immune abrogation being the cardinal features of HIV-1 infection, accumulating evidence indicates that GBV-C effectively overturns HIV's chances of exploiting the T-cell machinery and leads to enhanced survival rates of HIV-infected subjects. Much effort has been devoted to understanding the beneficial role of GBV-C in HIV disease. This review discusses recently proposed mechanisms underlying the pathophysiology of GBV-C coinfection in HIV disease.
More Related Videos
Related Concept Videos
Cytomegalovirus Disease
Viral Hepatitis I: Introduction
Hepatitis
Cryptococcal Meningitis
Encephalitis ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology

